Skip to main content
Article thumbnail
Location of Repository

Transmission of Plasmodium vivax in South-Western Uganda: Report of Three Cases in Pregnant Women

By Mehul Dhorda, Dan Nyehangane, Laurent Rénia, Patrice Piola, Philippe J Guerin and Georges Snounou


Plasmodium vivax is considered to be rare in the predominantly Duffy negative populations of Sub-Saharan Africa, as this red blood cell surface antigen is essential for invasion by the parasite. However, despite only very few reports of molecularly confirmed P. vivax from tropical Africa, serological evidence indicated that 13% of the persons sampled in Congo had been exposed to P. vivax. We identified P. vivax by microscopy in 8 smears from Ugandan pregnant women who had been enrolled in a longitudinal study of malaria in pregnancy. A nested polymerase chain reaction (PCR) protocol was used to detect and identify the Plasmodium parasites present. PCR analysis confirmed the presence of P. vivax for three of the women and analysis of all available samples from these women revealed clinically silent chronic low-grade vivax infections for two of them. The parasites in one woman carried pyrimethamine resistance-associated double non-synonymous mutations in the P. vivax dihydrofolate reductase gene. The three women found infected with P. vivax were Duffy positive as were nine of 68 women randomly selected from the cohort. The data presented from these three case reports is consistent with stable transmission of malaria in a predominantly Duffy negative African population. Given the substantial morbidity associated with vivax infection in non-African endemic areas, it will be important to investigate whether the distribution and prevalence of P. vivax have been underestimated in Sub-Saharan Africa. This is particularly important in the context of the drive to eliminate malaria and its morbidity

Year: 2011
DOI identifier: 10.1371/journal.pone.0019801
OAI identifier:
Provided by: MSF Field Research

Suggested articles


  1. (1922). A new malaria parasite of man.
  2. (1999). Effects of Plasmodium vivax malaria in pregnancy.
  3. (2010). Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
  4. (1999). Emergence of FY*Anull in a Plasmodium vivax-endemic region of Papua New Guinea.
  5. (1999). Epidemiology of malaria in pregnancy in central India.
  6. (2009). Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa.
  7. (2006). Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in Western Kenya.
  8. (2008). Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing.
  9. (2007). Genetic polymorphisms influence Plasmodium ovale PCR detection accuracy.
  10. (1993). High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction.
  11. (2001). Imported Plasmodium vivax malaria in France: geographical origin and report of an atypical case acquired in Central or Western Africa.
  12. (2004). Malaria in pregnancy and the endemicity spectrum: what can we learn?
  13. (2002). Nested PCR analysis of Plasmodium parasites.
  14. (1998). Nonimmune patients in the Democratic Republic of Sa˜o Tome´ e Principe reveal a high level of transmission of P. ovale and P. vivax despite low frequency in immune patients.
  15. (1932). Note on experimental infection of Anopheles punctipennis with quartan malaria.
  16. (2003). Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure.
  17. (2005). Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report.
  18. (2007). Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
  19. (1966). Plasmodium ovale, Plasmodium simium, Plasmodium fieldi and Plasmodium simiovale. Malaria parasites and other haemosporidia. Oxford: Blackwell Scientific Publications.
  20. (2010). Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people.
  21. (2007). Plasmodium vivax in Africa: hidden in plain sight?
  22. (2007). Plasmodium vivax infection among Duffy antigennegative individuals from the Brazilian Amazon region: an exception? Trans R Soc Trop Med Hyg
  23. (2007). Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes.
  24. (1999). Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites Plasmodium vivax Transmission in Uganda PLoS
  25. (2010). The international limits and population at risk of Plasmodium vivax transmission in
  26. (1976). The resistance factor to Plasmodium vivax in blacks. The Duffy-blood- group genotype,
  27. (1958). The susceptibility of Liberians to the Madagascar strain of Plasmodium vivax.
  28. (1999). Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.